# Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men

> **NCT02236988** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Apremilast Immediate Release
- **DRUG:** Apremilast Modified Release 1
- **DRUG:** Apremilast Modified Release 2
- **DRUG:** Apremilast Modified Release 3
- **DRUG:** Apremilast Modified Release 4
- **DRUG:** Apremilast Modified Release 5
- **DRUG:** Apremilast Modified Release 6
- **DRUG:** Apremilast Modified Release 8
- **DRUG:** Apremilast Modified Release 9
- **DRUG:** Apremilast Modified Release 11
- **DRUG:** Apremilast Modified Release 12
- **DRUG:** Apremilast Modified Release 13
- **DRUG:** Apremilast Modified Release 14

## Key facts

- **NCT ID:** NCT02236988
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-07
- **Primary completion:** 2014-09-11
- **Final completion:** 2014-09-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236988, "Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02236988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*